STOCKS CLIMB AFTER COOL U.S. PCE DATA RAISE RATE-CUT HOPES

Fed's preferred inflation gauge shows prices rose at slowest pace since March 2021

TARS Oct 2024 17.500 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

1.3100

0.0000

(0.00%)

As of 02:13PM EDT. Market open.

Loading interactive chart...

GlobeNewswire
Tarsus to Participate in Upcoming Investor Conferences
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in the following conferences: William Blair Growth Stock Conference Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Tuesday, June 4, 2024, at 1:20 p
Simply Wall St.
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates
Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) just released its latest first-quarter results and things are looking...
Simply Wall St.
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Tarsus Pharmaceuticals ( NASDAQ:TARS ) First Quarter 2024 Results Key Financial Results Revenue: US$27.6m (up by...